D 253 LYS 5 -9.786 -9.236
D 254 LEU 11 -12.986 -12.758
D 255 CYS 13 -14.572 -14.391
D 256 SER 3 -12.203 -11.145
D 257 LEU 4 -12.306 -11.351
D 258 ASP 5 -13.169 -12.230
D 259 ASN 13 -14.970 -14.743
D 260 GLY 21 -15.394 -16.039
D 261 ASP 6 -15.071 -14.028
D 262 CYS 23 -16.849 -17.557
D 263 ASP 18 -16.217 -16.422
D 264 GLN 17 -16.557 -16.608
D 265 PHE 15 -16.767 -16.564
D 266 CYS 14 -17.397 -17.006
D 267 HIS 9 -15.334 -14.605
D 268 GLU 10 -12.852 -12.524
D 269 GLU 8 -10.788 -10.468
D 270 GLN 4 -8.438 -7.928
D 271 ASN 0 -7.619 -6.743
D 272 SER 5 -11.435 -10.695
D 273 VAL 21 -14.358 -15.122
D 274 VAL 5 -16.109 -14.831
D 275 CYS 20 -17.911 -18.151
D 276 SER 6 -16.896 -15.643
D 277 CYS 20 -16.904 -17.260
D 278 ALA 8 -15.133 -14.313
D 279 ARG 0 -11.780 -10.426
D 280 GLY 7 -10.228 -9.857
D 281 TYR 20 -12.980 -13.788
D 282 THR 4 -14.350 -13.160
D 283 LEU 14 -15.400 -15.239
D 284 ALA 10 -13.743 -13.313
D 285 ASP 0 -11.860 -10.496
D 286 ASN 9 -12.440 -12.044
D 287 GLY 9 -14.652 -14.002
D 288 LYS 12 -15.907 -15.457
D 289 ALA 6 -15.825 -14.695
D 290 CYS 23 -16.221 -17.001
D 291 ILE 7 -13.482 -12.737
D 292 PRO 9 -9.954 -9.844
D 293 THR 8 -8.949 -8.840
D 294 GLY 10 -6.211 -6.647
D 295 PRO 1 -4.287 -3.909
D 296 TYR 2 -5.752 -5.321
D 297 PRO 15 -8.259 -9.034
D 298 CYS 8 -8.809 -8.716
D 299 GLY 12 -8.979 -9.326
D 300 LYS 19 -7.009 -8.388
D 301 GLN 1 -4.350 -3.964
D 302 THR 4 -2.669 -2.822 <=B
D 303 LEU 2 -2.081 -2.072 <=B
D 304 GLU 0 -0.723 -0.640 <=B

Identified 3 B-Cell epitope residues out of 52 total residues